CC
MRK icon

Claybrook Capital’s Merck MRK Stock Holding History

Claybrook Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-28,909
Closed -$2.37M – 136
2022
Q1 		$2.37M Sell
28,909
-500
-2% -$39.4K 1.18% 22
2021
Q4 		$2.25M Buy
29,409
+99
+0.3% +$7.88K 1.06% 30
2021
Q3 		$2.2M Sell
29,310
-21,946
-43% -$1.67M 1.11% 27
2021
Q2 		$3.99M Buy
51,256
+30,820
+151% +$2.29M 1.3% 20
2021
Q1 		$1.5M Buy
20,436
+3,144
+18% +$232K 0.87% 40
2020
Q4 		$1.35M Hold
17,292
– – 0.89% 37
2020
Q3 		$1.37M Buy
17,292
+1,048
+6% +$82.1K 1.03% 35
2020
Q2 		$1.2M Buy
16,244
+12,576
+343% +$947K 1.03% 35
2020
Q1 		$269K Hold
3,668
– – 0.24% 66
2019
Q4 		$300K Hold
3,668
– – 0.14% 94
2019
Q3 		$295K Hold
3,668
– – 0.15% 90
2019
Q2 		$293K Hold
3,668
– – 0.15% 88
2019
Q1 		$291K Buy
3,668
+772
+27% +$57.7K 0.15% 85
2018
Q4 		$211K Sell
2,896
-4,492
-61% -$317K 0.06% 131
2018
Q3 		$500K Sell
7,388
-20,279
-73% -$1.29M 0.29% 62
2018
Q2 		$1.6M Hold
27,667
– – 1% 34
2018
Q1 		$1.44M Buy
27,667
+6,131
+28% +$331K 0.94% 33
2017
Q4 		$1.16M Buy
+21,536
New +$1.19M 0.82% 32

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Claybrook Capital's MRK Position: Q2 2022 in Review

Claybrook Capital sold out of Merck (MRK) in Q2 2022, closing a stake of 28,909 shares — an estimated $2.37M sold.

Claybrook Capital first reported a position in MRK in Q4 2017 and held it in 18 quarters. The position peaked at $3.99M in Q2 2021. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Claybrook Capital reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Claybrook Capital sold 28,909 Merck shares in Q2 2022, an estimated $2.37M.
  • Claybrook Capital first reported a position in Merck in Q4 2017 and held it in 18 quarters.
  • Claybrook Capital's Merck position peaked at $3.99M in Q2 2021.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Claybrook Capital's 13F filing for Q2 2022, filed 18 Jul 2022.